Description In vitro In vivo
ChemicalBook > CAS DataBase List > GDC-0941 Bimesylate

GDC-0941 Bimesylate

Description In vitro In vivo
Product Name
GDC-0941 Bimesylate
CAS No.
957054-33-0
Chemical Name
GDC-0941 Bimesylate
Synonyms
GDC-0941 Bimesylate;Pictilisib mesylate;GDC-0941 dimesylate;Pictilisib (GDC-0941);GDC-0941 (2 MeSO3H salt);GDC 0941 (2 MeSO3H salt);GDC-0941 (diMethanesulfonate);Pictilisib dimethanesulfonate;GDC-0941 Bimesylate USP/EP/BP;GDC-0941 BiMesylate/pictilisib
CBNumber
CB82509226
Molecular Formula
C24H30N7O6S3
Formula Weight
608.7333
MOL File
957054-33-0.mol
More
Less

GDC-0941 Bimesylate Property

Melting point:
>280°C (dec.)
storage temp. 
Refrigerator
solubility 
DMSO (Slightly, Heated), Methanol (Sparingly)
form 
Solid
color 
White to Pale Yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Usbiological
Product number
012740
Product name
GDC-0941 Bimesylate
Packaging
10mg
Price
$460
Updated
2021/12/16
TRC
Product number
G300000
Product name
GDC-0941Bimesylate
Packaging
50mg
Price
$790
Updated
2021/12/16
ApexBio Technology
Product number
A3432
Product name
GDC-0941dimethanesulfonate
Packaging
10mg
Price
$50
Updated
2021/12/16
ChemScene
Product number
CS-0082
Product name
Pictilisib(dimethanesulfonate)
Purity
99.31%
Packaging
10mg
Price
$60
Updated
2021/12/16
ChemScene
Product number
CS-0082
Product name
Pictilisib(dimethanesulfonate)
Purity
99.31%
Packaging
50mg
Price
$90
Updated
2021/12/16
More
Less

GDC-0941 Bimesylate Chemical Properties,Usage,Production

Description

Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.

In vitro

GDC-0941 is equipotent against PI3Kα and PI3Kδ as well as PI3Kα mutants E545-K and H1047-R, displaying modest levels of selectivity against PI3Kβ (10-fold) and PI3Kγ (25-fold), and greater levels of selectivity against members of PI3K class II, III, and IV, including C2β, Vps34, DNA-PK, and mTOR. GDC-0941 potently inhibits the phosphorylation of Akt in U87MG, PC3, and MDA-MB-361 cells with IC50 of 46 nM, 37 nM, and 28 nM, respectively. GDC-0941 inhibits the proliferation of U87MG, A2780, PC3, and MDA-MB-361 cells with IC50 of 0.95 μM, 0.14 μM, 0.28 μM, and 0.72 μM, respectively. GDC-0941 treatment potently inhibits the proliferation of both trastuzumab-sensitive and-insensitive HER2-amplified cells with IC50 of 149-944 nM. GDC-0941 inhibits proliferation of HER2-amplified cells that harbor PIK3CA mutations with IC50 of <500 nM, and effectively inhibits both proliferation and viability of HER2-amplified breast cancer cells that are resistant to trastuzumab due to PTEN loss. GDC-0941 significantly inhibits the growth of HCT116, DLD1 and HT29 cells with GI50 of 1081 nM, 1070 nM and 157 nM, respectively. GDC-0941 inhibits tumor cell proliferation, induces apoptosis and suppresses centroblast population.

In vivo

Administration of GDC-0941 at 75 mg/kg/day displays significant inhibitory effect against established human U87MG glioblastoma xenografts in female NCr athymic mice, with tumor growth inhibition of 83%. Oral administration of GDC-0941 at 150 mg/kg/day inhibits the growth of HER2-amplified, trastuzumab-resistant MDA-MB-361.1 xenografts in mice, and significantly delays the tumor progression, in association with potent induced apoptosis in tumors. GDC-0941 (75 mg/kg/day) treatment for 2 weeks induces ~40% reduction in tumor volume of spontaneous B-cell follicular lymphomas developed in PTEN+/-LKB1+/hypo mice, accompanied by ablation of phosphorylation of Akt, S6K and SGK (serum and glucocorticoid protein kinase) protein kinases.

Chemical Properties

Off-White Solid

Uses

Potent inhibitor of Phosphatidylinositol 3-kinase (PI3K)

Biological Activity

gdc-0941 is a novel selective class i phosphatidylinositol-3-kinase (pi3k) inhibitor. activation of pi3k/akt signaling pathway is frequently associated with tumorigenesis. deregulation of this pathway occurs frequently with a variety of cancers and may contribute to the resistance to many anticancer agents. [1] developing novel small molecules that specifically block the pi3k/akt pathway may inhibit tumor growth. gdc-0941 is designed to bind the atp-binding pocket of pi3k and to prevent formation of phosphatidylinositol-3, 4, 5-triphosphate (pip3), a second messenger that transmits pi3k downstream signals. [2, 3] it binds to pi3k in an atp-competitive manner.gdc-0941 is a potent small-molecule thieno [3, 2-d] pyrimidine inhibitor of the class i pi3k. it is highly selective against isoforms p110( and p110( with ic50 of 3 nm, and moderately selective against isoforms p110( and p110( with ic50s of 33 nm and 75 nm, respectively.gdc-0941 inhibits cell proliferation in vitro and in vivo. it causes growth inhibition in a variety of cancer cell lines, including a2780, mda-mb-361, pc3, and u87mg. [2] it also inhibits the growth of trastuzumab–sensitive and –resistant her2-amplied cancer cells which harbor p110( mutations or pten loss. [4] gdc-0941 also reduces tumor volume in different xenograft models. [4]gdc-0941 can be taken orally.

in vivo

Pictilisib (GDC-0941) (150 mg/kg, p.o.) leads to tumor stasis in MCF7-neo/HER2-bearing animals model. Pictilisib (GDC-0941) and RP-56976 result in tumor regressions during the treatment period leading to enhanced antitumor responses[1]. Tumours in the Pictilisib (GDC-0941)-treated mice show a marked non-linear shrinkage, and when the Pictilisib (GDC-0941) treatment ceased, the tumours in the test cohort mice grow again[2]. GDC-0941Pictilisib (GDC-0941) (25 or 50 mg/kg) reduces tumor growth and PI3K and HIF-1 pathway activity in eGFP-FTC133 tumor-bearing mice[4].

target

PI3Kα

IC 50

p110α: 3 nM (IC50); p110α-H1047R: 3 nM (IC50); p110α-E545K: 3 nM (IC50); p110δ: 3 nM (IC50); p110β: 33 nM (IC50); p110γ: 75 nM (IC50); mTOR: 0.58 μM (Ki); DNA-PK: 1.23 μM (IC50); Autophagy

References

[1]yuan tl, cantley lc. pi3k pathway alterations in cancer: variations on a theme. oncogene. 2008;27:5497-5510.
[2]folkes aj, ahmadi k, alderton wk, et al. the identification of 2-(1h-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (gdc-0941) as a potent, selective, orally bioavailable inhibitor of class i pi3 kinase for the treatment of cancer. j med chem. 2008; 51: 5522-5532.
[3]knight za, shokat km. chemically targeting the pi3k family. biochem soc trans. 2007; 35: 245-249.
[4]junttila tt, akita rw, parsons k, fields c, lewis phillips gd, friedman ls, sampath d, sliwkowski mx. ligand-independent her2/her3/pi3k complex is disrupted by trastuzumab and is effectively inhibited by the pi3k inhibitor gdc-0941. br j cancer. 2011; 104(7): 1116-25.

GDC-0941 Bimesylate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

GDC-0941 Bimesylate Suppliers

Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
Shangchem Co., Ltd.
Tel
+86-21-68182121
Fax
+86-21-68182121
Country
China
ProdList
882
Advantage
52
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32321
Advantage
50
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
Fax
+86 (21) 6129-4103
Country
China
ProdList
9756
Advantage
58
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4769
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Guangzhou QiYun Biotechnology Co., Ltd.
Tel
020-61288194 61288195
Fax
020-61288700
Email
505721671@qq.com
Country
China
ProdList
3866
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
Shanghai Changyan Chem & Tech Co., Ltd.
Tel
021-20242659 18930833303
Fax
+86 (21) 2024-2659
Email
Sales@changyanchem.cn
Country
China
ProdList
5001
Advantage
55
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Shanghai Rechem science Co., Ltd.
Tel
021-31433387 15618786686
Fax
QQ:1369748377
Email
sales@rechemscience.com
Country
China
ProdList
2991
Advantage
58
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
9125
Advantage
58
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131957
Advantage
58
Twochem Co.Ltd.
Tel
021-58111628 15800915896
Fax
QQ 3285589261
Email
sales@twochem.com
Country
China
ProdList
1788
Advantage
58
Nanjing crow LuNing pharmaceutical technology co., LTD
Tel
13382066392
Country
CHINA
ProdList
4877
Advantage
58
Angel Pharmatech, Ltd.
Tel
17317130613
Fax
QQ3358272972
Email
3358272972@qq.com
Country
China
ProdList
3277
Advantage
58
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 +86-13028896684;
Email
sales@rrkchem.com
Country
China
ProdList
57422
Advantage
58
Fan De(Beijing) Biotechnology Co., Ltd.
Tel
15911056312
Email
liming@bio-fount.com
Country
China
ProdList
9729
Advantage
58
Aishilun biotechnology (Shanghai) co., LTD
Tel
021-50676523 18019098996
Email
info@acelybio.com
Country
China
ProdList
3960
Advantage
58
Zhejiang J&C Biological Technology Co.,Limited
Tel
+1-2135480471
Email
sales@sarms4muscle.com
Country
China
ProdList
10473
Advantage
58
Hefei TNJ Chemical Industry Co.,Ltd.
Tel
+86-0551-65418684 +8618949823763
Fax
0086-551-65418684
Email
sales@tnjchem.com
Country
China
ProdList
25356
Advantage
58
Dideu Industries Group Limited
Tel
+86-29-89586680 +86-15129568250
Email
1026@dideu.com
Country
China
ProdList
20284
Advantage
58
Ningbo Haorui Biological Technology Co., Ltd.
Tel
15221000252
Email
278450236@qq.com
Country
China
ProdList
203
Advantage
58
Hubei xin bonus chemical co. LTD
Tel
86-13657291602
Fax
027-59338440
Email
linda@hubeijusheng.com
Country
CHINA
ProdList
22963
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
career henan chemical co
Tel
+86-0371-86658258 +8613203830695
Fax
0086-371-86658258
Email
factory@coreychem.com
Country
China
ProdList
29798
Advantage
58
Shanghai Zeye Biotechnology Co., Ltd.
Tel
021-021-61998551 13122364865
Email
sale1@shzysw.net
Country
China
ProdList
9778
Advantage
58
Guangzhou Younan Technology Co., Ltd
Tel
020-82000279 18988941452
Fax
QQ:3283937693
Email
YN_research@163.com
Country
China
ProdList
3011
Advantage
58
Absin Bioscience Inc.
Tel
021-38015121 18438616290
Email
lanwu@univ-bio.com
Country
China
ProdList
24731
Advantage
58
Shanghai Luofa Biochemical Technology Co., Ltd.
Tel
021-51111890 15317326293
Email
sales@molnova.com
Country
China
ProdList
4195
Advantage
58
Chunchuang (Wuhan) Technology Co., Ltd
Tel
15727060112
Email
yutianchun2007@126.com
Country
China
ProdList
9814
Advantage
58
Wuhan Yanzhe Technology Co., Ltd
Tel
15527250409
Fax
QQ:2692360204
Email
wenhaotian12@163.com
Country
China
ProdList
4171
Advantage
58
MedBioPharmaceutical Technology Inc
Tel
021-69568360 18916172912
Email
order@med-bio.cn
Country
China
ProdList
8140
Advantage
58
Ningbo yirui biology science and technology co., ltd
Tel
15221000252
Email
278450236@qq.com
Country
China
ProdList
370
Advantage
58
cjbscvictory
Tel
13348960310
Email
3003867561@qq.com
Country
China
ProdList
10503
Advantage
58
Abmole Bioscience Inc.
Tel
021-50967598 02150967598
Email
sales@abmole.cn
Country
China
ProdList
4494
Advantage
58
Jinan Jiuli Biotechnology Co. , Ltd.
Tel
15865264761
Email
486064515@qq.com
Country
China
ProdList
4810
Advantage
58
Hebei Weite Medical Technology Co., Ltd
Tel
13180081292 13180081292
Email
contact@wetogethermed.com
Country
China
ProdList
7949
Advantage
58
Allbio pharm Co., Ltd
Tel
1483287082 19962651230
Email
sales@allbiopharm.com
Country
China
ProdList
1529
Advantage
58
Kaifeng Mingren Pharmaceutical Co.,LTD
Tel
0371-65741762
Fax
QQ:2860768577
Email
sales@hasunny.com
Country
China
ProdList
2380
Advantage
58
InvivoChem
Tel
13549236410
Email
sales@invivochem.cn
Country
China
ProdList
6753
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Tel
400-6206333 13167063860
Email
anhua.mao@aladdin-e.com
Country
China
ProdList
48457
Advantage
58
Shanghai jerryxing Biomedical Technology Co., Ltd
Tel
17721492509; 17721492509
Email
643638326@qq.com
Country
China
ProdList
4970
Advantage
58
Changsha Fuzhen Biotechnology Co.,LTD
Tel
0731-13823398 15111215862
Email
313359644@qq.com
Country
China
ProdList
4161
Advantage
58
RD International Technology Co., Limited
Tel
18024082417
Email
market@ubiochem.com
Country
China
ProdList
9835
Advantage
58
Sangon Biotech (Shanghai) Co.,Ltd.
Tel
400-821-026
Email
Sales@sangon.com
Country
China
ProdList
6710
Advantage
58
More
Less

View Lastest Price from GDC-0941 Bimesylate manufacturers

Career Henan Chemical Co
Product
Pictilisib dimethanesulfonate 957054-33-0
Price
US $9.80/KG
Min. Order
1KG
Purity
≥98%
Supply Ability
20 tons
Release date
2020-01-02
Career Henan Chemical Co
Product
Pictilisib dimethanesulfonate 957054-33-0
Price
US $9.80/KG
Min. Order
1KG
Purity
≥98%
Supply Ability
20 tons
Release date
2019-12-31

957054-33-0, GDC-0941 BimesylateRelated Search:


  • GDC 0941 bismesylate - Pictilisib
  • Pictilisib dimethanesulfonate
  • PICTILISIB DIMETHANESULFONATE;GDC-0941 (2 MESO3H SALT);GDC0941 DIMETHANESULFONATE;GDC-0941;GDC0941;GDC 0941
  • GDC-0941 Bimesylate
  • GDC-0941 (diMethanesulfonate)
  • GDC 0941 (2 MeSO3H salt)
  • GDC-0941 (2 MeSO3H salt)
  • GDC-0941 BiMesylate/pictilisib
  • 2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine methanesulfonate (1:2)
  • Pictilisib (GDC-0941)
  • GDC-0941 bimesylate salt, Pictilisib dimethanesulfonate
  • Pictilisib (GDC-0941) dimethanesulfonate
  • PICTILISIB DIMETHANESULFONATE;GDC-0941 (2 MESO3H SALT);GDC-0941
  • Pictilisib mesylate
  • Thieno[3,2-d]pyrimidine,2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-,methanesulfonate(1:2)
  • GDC-0941 Bimesylate USP/EP/BP
  • Pictilisib (GDC-0941) mesylate
  • GDC 0941,inhibit,Inhibitor,GDC-0941 2 MeSO3H,Pictilisib,GDC0941,PI3K,Phosphoinositide 3-kinase,GDC-0941,Apoptosis,Pictilisib dimethanesulfonate,Autophagy
  • GDC-0941 dimesylate
  • 4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)-piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)-morpholine bis-methanesulfonate
  • Pictilisib dimethanesulfonate, 10 mM in DMSO
  • 2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine methanesulfona
  • GDC-0941 dimethanesulfonate (Pictilisib dimethanesulfonate)
  • 957054-33-0
  • C23H27N7O3S22CH4O3S
  • C25H35N7O9S4
  • CH4O3SC23H27N7O3S2
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Protein Kinase Inhibitors and Activators